4//SEC Filing
Skerlj Renato 4
Accession 0001628280-20-009293
CIK 0001501697other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:32 PM ET
Size
5.6 KB
Accession
0001628280-20-009293
Insider Transaction Report
Form 4
Skerlj Renato
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2020-06-10+50,000→ 50,000 totalExercise: $8.69Exp: 2030-06-09→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on June 10, 2021, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option on the last day of each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001814632
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 5:32 PM ET
- Size
- 5.6 KB